4N5-53842-61301 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-18
Dose 1 — Moderna
2021-05-16
Dose 2 — Moderna
2021-05-17
Registered in v-safe
2021-05-17
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema, Injection site nodule — Feeling: Good

Free text: On injection site first dose of vaccination there is a slight skin protrusion that gets red when it is under the heat or when it is pressed.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-18
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema — Feeling: Good · Site: Redness

Free text: The mild redness on injection site of the first dose vaccination is persistently there with protrusion. Nothing observed for the 2nd dose injection site so far.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema, Injection site swelling — Feeling: Good · Site: Redness

Free text: Still same spot where redness is observed with skin protrusion from first dose injection site.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema, Injection site reaction — Feeling: Good · Site: Redness

Free text: Same as yesterday, first dose injection site has slight redness and skin protrusion. No other side effects from 2nd dose injection site yet.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-21
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema — Feeling: Good · Site: Redness

Free text: Redness only on first shot injection site.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-23
Survey response — day 7, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Good

Free text: Extended menstrual period after 2nd dose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-30
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-06-06
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-13
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-20
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-27
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-08-15
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-14
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-21
Dose 3 — Moderna
2022-07-22
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-18	Moderna
2	2021-05-16	Moderna
3	2022-01-21	Moderna	No

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-17

Systemic reaction (other): On injection site first dose of vaccination there is a slight skin protrusion that gets red when it is under the heat or when it is pressed.

2021-05-18

Systemic reaction (other): The mild redness on injection site of the first dose vaccination is persistently there with protrusion. Nothing observed for the 2nd dose injection site so far.

2021-05-19

Systemic reaction (other): Still same spot where redness is observed with skin protrusion from first dose injection site.

2021-05-20

Systemic reaction (other): Same as yesterday, first dose injection site has slight redness and skin protrusion. No other side effects from 2nd dose injection site yet.

2021-05-21

Systemic reaction (other): Redness only on first shot injection site.

Release 8 — day 7, dose 2

2021-05-23

Systemic reaction (other): Extended menstrual period after 2nd dose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Heavy menstrual bleeding	✓	✓	✓
SRO	Injection site erythema	✓	✓	✓
SRO	Injection site nodule	✓	✓	✓
SRO	Injection site reaction	✓	✓	✓
SRO	Injection site swelling	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release